Chemoinformaics analysis of 2,3-Dimethylpyridine
Molecular Weight | 107.156 | nRot | 0 |
Heavy Atom Molecular Weight | 98.084 | nRig | 5 |
Exact Molecular Weight | 107.074 | nRing | 1 |
Solubility: LogS | -0.276 | nHRing | 1 |
Solubility: LogP | 0.503 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 17 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
nHA | 1 | APOL | 18.7911 |
nHD | 0 | BPOL | 10.1689 |
QED | 0.594 |
Synth | 2.795 |
Natural Product Likeliness | -0.505 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.012 |
HIA | 0.006 |
CACO-2 | -4.435 |
MDCK | 0.0000309 |
BBB | 0.721 |
PPB | 0.716387 |
VDSS | 2.989 |
FU | 0.495111 |
CYP1A2-inh | 0.323 |
CYP1A2-sub | 0.299 |
CYP2c19-inh | 0.075 |
CYP2c19-sub | 0.299 |
CYP2c9-inh | 0.021 |
CYP2c9-sub | 0.191 |
CYP2d6-inh | 0.008 |
CYP2d6-sub | 0.487 |
CYP3a4-inh | 0.006 |
CYP3a4-sub | 0.252 |
CL | 7.574 |
T12 | 0.854 |
hERG | 0.028 |
Ames | 0.101 |
ROA | 0.638 |
SkinSen | 0.222 |
Carcinogencity | 0.861 |
EI | 0.984 |
Respiratory | 0.759 |
NR-Aromatase | 0.004 |
Antiviral | No |
Prediction | 0.911779 |